Clinical Research Comparing Effects Of Novel MDMA Matches In Healthy Patients Begins In Switzerland
The clinical trial investigating the effects of MDMA analogs in healthy volunteers led by PI Prof. Dr. Matthias Liechti and supported by psychedelics biotech company Mind Medicine Inc. (NASDAQ: MNMD) has begun patient dosing.
